Specialist Updates 
Cardiology

Imaging useful to stratify risk in patients with FH: study

If findings are confirmed, wider use of CT angiography may aid therapy choices, a researcher says 
0
10 August 2021
Save
Please login to bookmark Close

AusDoc brings you the latest news from the Cardiac Society of Australia and New Zealand virtual annual scientific meeting, CSANZ 2021.

The presence of three or more high-risk plaques is a strong predictor of future atherosclerotic cardiovascular events in patients with familial hypercholesterolaemia (FH), Australian researchers say.

Their findings suggest that coronary computed tomographic angiography (CCTA) could play a pivotal role in cardiovascular disease risk stratification in this patient cohort.

The first-of-its-kind study evaluated the prognostic value of two advanced CCTA markers – high-risk plaque and pericoronary adipose tissue (PCAT) – in patients with FH.

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Content that breaches the privacy of other individuals
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .